Security key
92829J203
Dogwood Therapeutics, Inc. - Common Stock, par value $0.0001 (DWTX)
CUSIP: 92829J203
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock, par value $0.0001
- Total 13F shares
- 81,969
- Total 13F value
- $409,793
- Share change
- +51,199
- SEC-reported price per share
- $5.01
- Number of holders
- 13
- Value change
- +$256,592
- Number of buys
- 8
- Number of sells
- 2
- Shares outstanding
- 33,464,665
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
13
Top holders
10
DWTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Dogwood Therapeutics, Inc. SEC filings
Dogwood Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92829J203
Recent filing periods:
Ownership snapshot
Top reported holders of DWTX - Dogwood Therapeutics, Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Orca Capital AG
Disclosed value leader
William Pridgen
Comparable rows
11/14
Latest evidence
14 Mar 2025
13D/G
13F
3/4/5
Lead comparable stake: 3.7%
3 rows are not safely comparable across share classes.
13D/G row: Orca Capital AG
Showing 1-6 of 14 holder rows.
Quick read
Orca Capital AG leads the comparable SEC ownership view at 3.7%.
11 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Orca Capital AG's linked filing trail.
Comparable ownership
Top 5
Orca Capital AG
3.7%
UBS Group AG
0.05%
GEODE CAPITAL MANAGEMENT, LLC
0.03%
Tower Research Capital LLC (TRC)
0%
MORGAN STANLEY
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 14 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Orca Capital AG |
13D/G
|
3.7%
|
$390,299
69,821 shares
|
-$256,967 | 14 Mar 2025 |
| UBS Group AG |
13F
Company
|
0.05%
|
$44,001
17,671 shares
|
— | 31 Dec 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.03%
|
$27,116
10,933 shares
|
— | 31 Dec 2024 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0%
|
$2,420
972 shares
|
— | 31 Dec 2024 |
| MORGAN STANLEY |
13F
Company
|
0%
|
$1,494
600 shares
|
— | 31 Dec 2024 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
Company
|
0%
|
$949
381 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
13
Shares
81,969
Rows available
13
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
10
Q1 2025 holders
13
Holder diff
3
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend